Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Why don’t bats get cancer?
A study to look at why long-lived bats do not get cancer has broken new…
Racial differences in tumour collagen structure may impact cancer prognosis
In cancer care, accurate tools for predicting whether a tumour will metastasise can help patients…
Exploring how diet and the gastric microbiome shape gastric cancer risk
Gastric cancer (GC), commonly known as stomach cancer, ranks as the world’s fifth most common…
Lower screening age calls for more tailored bowel cancer surveillance
- Colon cancer rates are rising among young people – could changes to children’s gut bacteria explain why?
- AACR 2025: A liquid biopsy-based assay could detect recurrence prior to imaging in patients with resectable colorectal cancer
- Cell-free DNA testing: a promising future for colorectal cancer screening?
ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide
In a collaboration announced today, the American Society of Clinical Oncology, Inc.(ASCO) will work with the World Health Organization (WHO)…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.